ArticleRSC advances2024
Antibacterial efficacy of copper-based metal-organic frameworks against
Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Growth and orientation of copper gallate SURMOFs on cellulosic thin films.RSC advances · 2026Article
- The MOF-Microbiome Axis: a New Paradigm for Precision Nanomedicine.Probiotics and antimicrobial proteins · 2026Review
- Prebiotic Effects ofFood science & nutrition · 2026Article
- Copper-Based Metal-Organic Frameworks for Sustainable Catalysis: Mechanistic Insights, Stability, and Emerging Research Directions.ACS omega · 2026Review
- Antimicrobial EU@Ag-MOF/PLA composite films enhance postharvest quality of strawberries by mitigating oxidative stress and modulating microbial communities.Food chemistry: X · 2025Article
- Simultaneous antimicrobial and adsorptive capabilities of a novel surface-modified NHScientific reports · 2025Article
- Structural Speciation of Hybrid Ti(IV)-Chrysin Systems-Biological Profiling and Antibacterial, Anti-Inflammatory, and Tissue-Specific Anticancer Activity.Molecules (Basel, Switzerland) · 2025Article
- Reconstructing the Antibiotic Pipeline: Natural Alternatives to Antibacterial Agents.Biomolecules · 2025Review
- Recent advances in metal-organic frameworks for antibacterial applications: mechanisms and emerging strategies.RSC advances · 2025Review
- A Review on the Design Strategies of Copper-Based Catalysts for Enhanced Activity and Stability in Methanol Reforming to Hydrogen.Nanomaterials (Basel, Switzerland) · 2025Review
- Constructing Polymetallic Nodes in Metal-Organic Frameworks Enhance Antibacterial of Drug-Resistant Bacteria.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Article
- Computational and Experimental Study of Metal-Organic Frameworks (MOFs) as Antimicrobial Agents againstACS applied materials & interfaces · 2025Article
- Hybrid Lanthanide Metal-Organic Compounds with Flavonoids: Magneto-Optical Properties and Biological Activity Profiles.International journal of molecular sciences · 2025Article
- Tetrazolium iridium complexes as potential antibacterial agents.RSC advances · 2025Article
- Engineering copper and copper-based materials for a post-antibiotic era.Frontiers in bioengineering and biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The widespread and excessive use of antimicrobial drugs has resulted in a concerning rise in bacterial resistance, leading to a risk of untreatable infections. The aim of this study was to formulate a robust and efficient antibacterial treatment to address this challenge. Previous work focused on the effectiveness of the Cu-BTC metal-organic framework (MOF; BTC stands for 1,3,5-benzenetricarboxylate) in combatting various bacterial strains. Herein, we compare the antibacterial properties of Cu-BTC with our newly designed Cu-GA MOF, consisting of copper ions bridged by deprotonated gallate ligands (H
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.